These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25119903)

  • 21. Tyrosinase gene (TYR) mutations in Chinese patients with oculocutaneous albinism type 1.
    Liu J; Choy KW; Chan LW; Leung TY; Tam PO; Chiang SW; Lam DS; Pang CP; Lai TY
    Clin Exp Ophthalmol; 2010 Jan; 38(1):37-42. PubMed ID: 20447099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid genetic analysis of oculocutaneous albinism (OCA1) using denaturing high performance liquid chromatography (DHPLC) system.
    Lin SY; Chien SC; Su YN; Lee CN; Chen CP
    Prenat Diagn; 2006 May; 26(5):466-70. PubMed ID: 16570240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prenatal diagnosis of oculocutaneous albinism type II and discovery of two novel mutations].
    Li HY; Wei HY; Zheng H; Meng S; Jiang WY; Chen LM; Duan HL
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1123-5. PubMed ID: 17672996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal diagnosis of oculocutaneous albinism by analysis of the fetal tyrosinase gene.
    Shimizu H; Niizeki H; Suzumori K; Aozaki R; Kawaguchi R; Hikiji K; Nishikawa T
    J Invest Dermatol; 1994 Jul; 103(1):104-6. PubMed ID: 8027570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism.
    Preising MN; Forster H; Gonser M; Lorenz B
    Mol Vis; 2011 Apr; 17():939-48. PubMed ID: 21541274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism.
    Xiao Y; Zhou C; Xie H; Huang S; Wang J; Liu S
    BMC Genomics; 2022 Apr; 23(1):332. PubMed ID: 35488210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delineating Novel and Known Pathogenic Variants in
    Shakil M; Akbar A; Aisha NM; Hussain I; Ullah MI; Atif M; Kaul H; Amar A; Latif MZ; Qureshi MA; Mahmood S
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Causes of Oculocutaneous Albinism in Pakistani Population.
    Sajid Z; Yousaf S; Waryah YM; Mughal TA; Kausar T; Shahzad M; Rao AR; Abbasi AA; Shaikh RS; Waryah AM; Riazuddin S; Ahmed ZM
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33800529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prenatal diagnosis of oculocutaneous albinism type IV and discovery of a novel mutation].
    Pang T; Lei J; Zheng H; Xu B; Jiang WY; Li HY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Feb; 28(1):1-5. PubMed ID: 21287499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oculocutaneous albinism in French overseas territories (Reunion, French Guyana, Martinique) and Mayotte. Study of 21 cases in 16 families].
    Aquaron R; Berge-Lefranc JL; Badens C; Roche J; Fite A; Sainte-Marie D; Piquion N; Cartault F
    Med Trop (Mars); 2005 Nov; 65(6):584-91. PubMed ID: 16555521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SLC45A2 variations in Indian oculocutaneous albinism patients.
    Sengupta M; Chaki M; Arti N; Ray K
    Mol Vis; 2007 Aug; 13():1406-11. PubMed ID: 17768386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A novel P gene mutation in a Chinese family with oculocutaneous albinism].
    Duan HL; Li HY; Wu WQ; Zheng H; Chen Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):614-7. PubMed ID: 17160937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of Korean patients with oculocutaneous albinism.
    Park SH; Chae H; Kim Y; Kim M
    Jpn J Ophthalmol; 2012 Jan; 56(1):98-103. PubMed ID: 22042571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oculocutaneous albinism (OCA) in Japanese patients: five novel mutations.
    Okamura K; Yoshizawa J; Abe Y; Hanaoka K; Higashi N; Togawa Y; Nakagawa S; Kambe N; Funasaka Y; Ohko K; Hozumi Y; Suzuki T
    J Dermatol Sci; 2014 May; 74(2):173-4. PubMed ID: 24461674
    [No Abstract]   [Full Text] [Related]  

  • 35. Comprehensive analysis of the molecular basis of oculocutaneous albinism in Indian patients lacking a mutation in the tyrosinase gene.
    Sengupta M; Mondal M; Jaiswal P; Sinha S; Chaki M; Samanta S; Ray K
    Br J Dermatol; 2010 Sep; 163(3):487-94. PubMed ID: 20426782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive analysis reveals mutational spectra and common alleles in Chinese patients with oculocutaneous albinism.
    Wei A; Wang Y; Long Y; Wang Y; Guo X; Zhou Z; Zhu W; Liu J; Bian X; Lian S; Li W
    J Invest Dermatol; 2010 Mar; 130(3):716-24. PubMed ID: 19865097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a novel mutation (p.Ile198Thr) in gene TYR in a Pakistani family with nonsyndromic oculocutaneous albinism.
    Shah SA; Din SU; Raheem N; Daud S; Mubeen J; Nadeem A; Tayyab M; Baloch DM; Babar ME; Ahmad J
    Clin Exp Dermatol; 2014 Jul; 39(5):646-8. PubMed ID: 24934919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation spectrum of the TYR and SLC45A2 genes in patients with oculocutaneous albinism.
    Ko JM; Yang JA; Jeong SY; Kim HJ
    Mol Med Rep; 2012 Apr; 5(4):943-8. PubMed ID: 22294196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation analysis of a Chinese family with oculocutaneous albinism.
    Wang X; Zhu Y; Shen N; Peng J; Wang C; Liu H; Lu Y
    Oncotarget; 2016 Dec; 7(51):84981-84988. PubMed ID: 27829221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technical advances in prenatal diagnosis of tyrosinase-negative oculocutaneous albinism.
    Shimizu H
    Acta Derm Venereol; 1997 Jan; 77(1):10-3. PubMed ID: 9059668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.